Indeed, Vδ1 cells, which are enriched in PB of CLL patients, can kill neoplastic CLL cell lines transfected with MICA, and blocking anti-NKG2D antibody largely decreases autologous leukemic cell lysis (21). This evidence concerns the gene KLRK1 and B-cell chronic lymphocytic leukemia.